Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KBDC Kayne Anderson BDC	$15.67 -1.0%	$16.03	$13.93 ▼ $17.99	$1.12B	N/A	92,681 shs	99,761 shs
MSDL Morgan Stanley Direct Lending	$19.24 +1.1%	$19.65	$17.59 ▼ $24.18	$1.69B	0.46	628,247 shs	355,512 shs
OBDE Blue Owl Capital Co. III	$14.14	$14.14	$13.60 ▼ $16.59	$1.74B	N/A	211,603 shs	N/A
REVH Revolution Healthcare Acquisition	$10.04	$10.04	$9.62 ▼ $10.50	$476.93M	0.04	183,205 shs	371 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KBDC Kayne Anderson BDC	+0.54%	-0.35%	+3.53%	-7.99%	+1,583,499,900.00%
MSDL Morgan Stanley Direct Lending	-1.09%	-2.21%	+3.93%	-8.29%	-15.04%
OBDE Blue Owl Capital Co. III	0.00%	0.00%	0.00%	0.00%	-9.59%
REVH Revolution Healthcare Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
KBDC Kayne Anderson BDC	0.6473 of 5 stars	1.3	3.0	1.7	0.0	1.7	0.0	0.0
MSDL Morgan Stanley Direct Lending	2.4801 of 5 stars	2.1	5.0	1.7	0.0	2.1	0.0	1.9
OBDE Blue Owl Capital Co. III	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
REVH Revolution Healthcare Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KBDC Kayne Anderson BDC	2.60	Moderate Buy	$16.60	5.97% Upside
MSDL Morgan Stanley Direct Lending	2.17	Hold	$20.20	4.99% Upside
OBDE Blue Owl Capital Co. III	0.00	N/A	N/A	N/A
REVH Revolution Healthcare Acquisition	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest REVH, OBDE, MSDL, and KBDC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/5/2025	KBDC Kayne Anderson BDC	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$18.00 ➝ $17.00
4/28/2025	KBDC Kayne Anderson BDC	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$17.00 ➝ $16.00
4/28/2025	MSDL Morgan Stanley Direct Lending	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$20.00 ➝ $19.00
4/24/2025	MSDL Morgan Stanley Direct Lending	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$20.50 ➝ $19.50
4/17/2025	KBDC Kayne Anderson BDC	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$16.50 ➝ $16.00
4/17/2025	MSDL Morgan Stanley Direct Lending	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$21.00 ➝ $20.50
4/8/2025	KBDC Kayne Anderson BDC	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$17.00 ➝ $16.50
4/8/2025	MSDL Morgan Stanley Direct Lending	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$21.00 ➝ $20.00
3/4/2025	MSDL Morgan Stanley Direct Lending	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$22.00 ➝ $22.00
3/3/2025	MSDL Morgan Stanley Direct Lending	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$21.00 ➝ $20.00

(Data available from 5/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KBDC Kayne Anderson BDC	$122.29M	9.13	N/A	N/A	N/A	∞
MSDL Morgan Stanley Direct Lending	$253.06M	6.68	$1.79 per share	10.75	$19.50 per share	0.99
OBDE Blue Owl Capital Co. III	$244.17M	7.14	$2.16 per share	6.54	$15.60 per share	0.91
REVH Revolution Healthcare Acquisition	N/A	N/A	$0.49 per share	20.62	($0.74) per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KBDC Kayne Anderson BDC	$77.07M	N/A	0.00	8.95	N/A	59.80%	12.65%	6.77%	5/12/2025 (Estimated)
MSDL Morgan Stanley Direct Lending	$231.01M	$2.43	7.55	8.12	N/A	54.89%	12.69%	6.52%	5/8/2025 (Estimated)
OBDE Blue Owl Capital Co. III	$271.96M	$1.76	8.03	9.75	N/A	45.35%	11.52%	5.22%	N/A
REVH Revolution Healthcare Acquisition	$21.35M	N/A	0.00	∞	N/A	N/A	-81.90%	3.65%	N/A

Latest REVH, OBDE, MSDL, and KBDC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/12/2025	N/A	KBDC Kayne Anderson BDC	$0.42	N/A	N/A	N/A	$58.43 million	N/A
5/8/2025	Q1 2025	MSDL Morgan Stanley Direct Lending	$0.57	$0.52	-$0.05	$0.34	$102.86 million	N/A
3/3/2025	Q4 2024	KBDC Kayne Anderson BDC	$0.51	$0.48	-$0.03	$0.50	$53.01 million	$56.34 million
2/27/2025	Q4 2024	MSDL Morgan Stanley Direct Lending	$0.63	$0.57	-$0.06	$0.58	$107.02 million	$103.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
KBDC Kayne Anderson BDC	$1.60	10.21%	N/A	N/A	N/A
MSDL Morgan Stanley Direct Lending	$2.00	10.40%	N/A	82.30%	N/A
OBDE Blue Owl Capital Co. III	$1.40	9.90%	N/A	79.55%	N/A
REVH Revolution Healthcare Acquisition	N/A	N/A	N/A	N/A	N/A

Latest REVH, OBDE, MSDL, and KBDC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/27/2025	MSDL Morgan Stanley Direct Lending	quarterly	$0.50	9.9%	3/31/2025	3/31/2025	4/25/2025
3/3/2025	KBDC Kayne Anderson BDC	quarterly	$0.40	9.7%	3/31/2025	3/31/2025	4/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KBDC Kayne Anderson BDC	0.66	1.36	1.36
MSDL Morgan Stanley Direct Lending	0.99	1.56	1.56
OBDE Blue Owl Capital Co. III	1.28	1.76	1.76
REVH Revolution Healthcare Acquisition	N/A	2.68	2.68

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KBDC Kayne Anderson BDC	N/A
MSDL Morgan Stanley Direct Lending	N/A
OBDE Blue Owl Capital Co. III	N/A
REVH Revolution Healthcare Acquisition	N/A

Insider Ownership

Company	Insider Ownership
KBDC Kayne Anderson BDC	3.20%
MSDL Morgan Stanley Direct Lending	0.21%
OBDE Blue Owl Capital Co. III	90.80%
REVH Revolution Healthcare Acquisition	1.23%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KBDC Kayne Anderson BDC	N/A	71.26 million	68.75 million	N/A
MSDL Morgan Stanley Direct Lending	N/A	87.92 million	88.31 million	Optionable
OBDE Blue Owl Capital Co. III	N/A	123.36 million	N/A	N/A
REVH Revolution Healthcare Acquisition	4	47.50 million	46.92 million	Not Optionable

REVH, OBDE, MSDL, and KBDC Headlines

Recent News About These Companies

Civil War and Revolution

November 2, 2024 | bbc.co.uk

National Symposium for Healthcare Executives

October 3, 2024 | uab.edu

In the healthcare and life sciences jungle – industry must adapt to survive

September 18, 2024 | pharmaphorum.com

Healthcare must embrace the digital revolution

August 30, 2024 | pharmaphorum.com

Health Care’s Value Revolution Focusing on Quality Over Quantity

July 30, 2024 | providermagazine.com

The AI Revolution In Healthcare: How Legacy Providers Can Adapt

July 29, 2024 | forbes.com

Revolution Bars Group Declines Nightcap Takeover Proposal

May 28, 2024 | marketwatch.com

The lowly Revolution are showing improvement, but they need an offensive upgrade to truly compete

May 13, 2024 | bostonglobe.com

Revolution Bars Considering All Options After Rival Nightcap Shows Interest

May 7, 2024 | marketwatch.com

Navigating the AI Revolution: Leadership Trends in Healthcare

April 10, 2024 | beckershospitalreview.com

Reviewing 10 Of Healthcare Boldest Moves In Recent History

February 4, 2024 | forbes.com

AI is on the cusp of a revolution

January 30, 2024 | healthcarefinancenews.com

The therapy revolution

June 15, 2023 | dailymail.co.uk

Syntax delivers index universes for Healthcare Innovations and Technology Revolution strategies on SmartTrust® UIT platform

June 1, 2023 | finance.yahoo.com

Healthcare Revolution: Medical Tourism and the American Dream

April 26, 2023 | finance.yahoo.com

Executive behind ChatGPT pushes for a new revolution: Psychedelics

April 25, 2023 | washingtonpost.com

Philips Healthcare's Revolution Rotational IVUS Imaging Catheter

March 26, 2023 | news-medical.net

Ali Health: A Revolution for China’s Healthcare Industry?

March 16, 2023 | thediplomat.com

NHS launches healthcare revolution to ditch drugs

March 1, 2023 | express.co.uk

LHC to delist from Nasdaq, suggesting UnitedHealth could complete acquisition next week

February 16, 2023 | healthcaredive.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

REVH, OBDE, MSDL, and KBDC Company Descriptions

Kayne Anderson BDC NYSE:KBDC

$15.66 -0.17 (-1.04%)

Closing price 03:58 PM Eastern

Extended Trading

$15.65 -0.01 (-0.10%)

As of 05:29 PM Eastern

Kayne Anderson BDC Inc. is a business development company which invests primarily in first lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle market companies. Kayne Anderson BDC Inc. is based in CHICAGO.

Morgan Stanley Direct Lending NYSE:MSDL

$19.24 +0.20 (+1.05%)

As of 03:58 PM Eastern

Morgan Stanley Direct Lending Fund is a business development company. It is a non-diversified, externally managed specialty finance company focused on lending to middle-market companies. Morgan Stanley Direct Lending Fund is based in NEW YORK.

Blue Owl Capital Co. III NYSE:OBDE

$14.14 0.00 (0.00%)

As of 01/24/2025

Blue Owl Capital Corporation is a specialty finance company focused on lending to U.S. middle-market companies. Blue Owl Capital Corporation is based in NEW YORK.

Revolution Healthcare Acquisition NASDAQ:REVH

Revolution Healthcare Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in health care, life sciences, and technology industries. The company was incorporated in 2021 and is based in Cambridge, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time